PDF
(Download)
|
- Cranberry (Vaccinium macrocarpon)
- Urinary Tract Infections
- Cardiovascular Health
|
Date:
06-13-2014 | HC# 021411-498
|
Re: Review of Cranberry Effects on Urinary Tract Infections and Cardiovascular Health
Blumberg JB, Camesano TA, Cassidy A, et al.
Cranberries and their bioactive constituents in human health. Adv Nutr. 2013;4(6):618-632.
Berry consumption has been associated with
numerous health benefits. In particular, cranberry (Vaccinium macrocarpon) is a rich source of polyphenolics that has exhibited
biological effects both in vitro and in vivo. This review focuses on the
bioactive components of cranberries and their potential effects on urinary tract infections (UTIs)
and cardiovascular health.
Bioactive Components of Cranberry
Some of the bioactive components of cranberries
include flavan-3-ols, anthocyanins, phenolic acids, ursolic acid derivatives, and flavonols.
These compounds vary in concentration depending on the cultivar and how the
berries have been processed (e.g., into juice or powder). In particular, anthocyanins
are lost the most from processing. Cranberry flavan-3-ols consist of monomers (e.g.,
epicatechin and catechin) and oligomers/polymers known as A-type
proanthocyanidins (A-type PACs). The monomer components of A-type PACs
(predominantly epicatechin) are connected together by a carbon-carbon bond and
a distinctive ether bond (A-type linkage). A-type PACs are a unique class of
condensed tannins that are found almost exclusively in cranberries (most plants
consist of B-type PACs) and are generally in the range of two to ten degrees of
polymerization. These fruits are also unique because they consist of sugar
derivatives from all six types of anthocyanins, a class of compounds that
contribute to the color of cranberries. Phenolic acids are also present, such
as hydroxycinnamic acids and the more prevalent hydroxybenzoic acid. Terpenoids
are also found in the form of two rare derivatives of ursolic acid. In
addition, flavonols are present mostly as glycosides, especially as quercetin 3-galactoside.
Cranberries and Urinary Tract Health
Cranberries are well known for their use
in the treatment of UTIs. Research has indicated that cranberry products may
prevent bacteria (P-fimbriated E. coli) from adhering to bladder epithelial
cells, and thereby treat or prevent UTIs. Another potential mechanism may
involve the effects that cranberries have on the gut microbiota. All of these
effects are mostly attributed to A-type PACs.
Clinical trials with cranberry
products have produced inconsistent results. Out of two meta-analysis studies, one
study indicated cranberry products had significant effects on UTIs. This
inconsistency in study results may be due to the variability in study designs, cranberry
products, and study compliance. It has also been noted that the pathogenesis of
UTIs may be different for young children, sexually active young adults, and the
elderly population. In one randomized double-blind
study, cranberry juice consumption significantly reduced urinary bacteria in an
elderly population after one month. Several
studies with adult women that had recurrent UTIs indicated that cranberry juice
and other cranberry products generally reduced the incidence of UTIs, although
not always significantly. This variability may be due to the lack of placebos, appropriate
placebos, or poor study designs. In three independent randomized trials, it was
found that cranberry juice had beneficial effects in children with recurrent
UTIs. Moreover, one trial indicated there was a correlation with anti-adherence
effects and clinical outcomes.
Cranberries and Cardiovascular Health
Cranberries may also provide
cardiovascular benefits by reducing cardiovascular disease (CVD) risk factors
associated with dyslipidemia, diabetes,
hypertension, inflammation, oxidative stress, endothelial dysfunction, arterial
stiffness, and platelet function. Clinical trials have shown that cranberry
products improved lipid profiles for patients with hypercholesterolemia, diabetes mellitus, and
hypertriglyceridemia. Other studies showed no effects in healthy subjects or
patients with CVD. Although several animal studies have indicated cranberries
reduce blood pressure, no clinical studies have shown these effects in patients
with diabetes mellitus and CVD. Moreover, cranberry supplementation
did not improve glycemic control in
patients with type 2 diabetes mellitus.
Several studies also showed that cranberry
products improved plasma antioxidant capacity and decreased oxidized
low-density lipoprotein cholesterol (LDL-C). There is, however, no proof that
these effects prevent oxidative damage to lipids or to DNA. Consumption of
cranberry juice also reduced inflammatory markers in middle-aged men, while
other studies indicated cranberry bioactive components had no effects. In terms of vascular function, cranberry supplementation or
bioactive components showed some improvements, although inconsistently, on
endothelial vasodilation and arterial stiffness. Different populations and
doses may contribute to these inconsistencies. Studies of other
polyphenolic-rich beverages and the cranberry anthocyanin, delphinidin-3-glucoside, suggest that cranberry consumption may
reduce platelet aggregation.
The benefits of compounds for which
cranberries are a good source have been evaluated
in several observational studies. Anthocyanin intake has been shown to lower
the risk for coronary heart disease (CHD), particularly in younger populations.
Studies suggest that these effects may be attributed to improvements in
arterial stiffness and blood pressure. There is less evidence that flavonols,
flavan-3-ols, or PACs prevent CHD.
Overall, it appears that consumption
of cranberries improves UTIs; although more studies are needed that carefully
assess dose responses in specific populations and use cranberry products with fully characterized
phytochemical profiles. It is less clear how effective
cranberries are on cardiovascular health, but one potential mechanism may
involve acute improvements on endothelial function. Regardless, much more
research is needed to properly evaluate the benefits that cranberry products
have on cardiovascular health. Even so, the authors suggest that guidance
regarding increased consumption of cranberry and other berry fruits to help
achieve a healthy dietary pattern is warranted based on their large array of
phytochemicals and micronutrients.
—Laura M. Bystrom, PhD
|